BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 32022432)

  • 1. Antibody response against Pseudomonas aeruginosa and its relationship with immune mediators in the upper and lower airways of cystic fibrosis patients.
    Mauch RM; Hentschel J; Aanaes K; Barucha A; Nolasco da Silva MT; Levy CE; Høiby N; Mainz JG
    Pediatr Pulmonol; 2020 Apr; 55(4):959-967. PubMed ID: 32022432
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Non-invasive assessment of upper and lower airway infection and inflammation in CF patients.
    Fischer N; Hentschel J; Markert UR; Keller PM; Pletz MW; Mainz JG
    Pediatr Pulmonol; 2014 Nov; 49(11):1065-75. PubMed ID: 24464968
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Colonization of CF patients' upper airways with S. aureus contributes more decisively to upper airway inflammation than P. aeruginosa.
    Janhsen WK; Arnold C; Hentschel J; Lehmann T; Pfister W; Baier M; Böer K; Hünniger K; Kurzai O; Hipler UC; Mainz JG
    Med Microbiol Immunol; 2016 Oct; 205(5):485-500. PubMed ID: 27377929
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Concordant genotype of upper and lower airways P aeruginosa and S aureus isolates in cystic fibrosis.
    Mainz JG; Naehrlich L; Schien M; Käding M; Schiller I; Mayr S; Schneider G; Wiedemann B; Wiehlmann L; Cramer N; Pfister W; Kahl BC; Beck JF; Tümmler B
    Thorax; 2009 Jun; 64(6):535-40. PubMed ID: 19282318
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Changes of Proteases, Antiproteases, and Pathogens in Cystic Fibrosis Patients' Upper and Lower Airways after IV-Antibiotic Therapy.
    Müller U; Hentschel J; Janhsen WK; Hünniger K; Hipler UC; Sonnemann J; Pfister W; Böer K; Lehmann T; Mainz JG
    Mediators Inflamm; 2015; 2015():626530. PubMed ID: 26185365
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Upper and lower airway cultures in children with cystic fibrosis: do not neglect the upper airways.
    Bonestroo HJ; de Winter-de Groot KM; van der Ent CK; Arets HG
    J Cyst Fibros; 2010 Mar; 9(2):130-4. PubMed ID: 20110197
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Importance of bacteriology in upper airways of patients with Cystic Fibrosis.
    Berkhout MC; Rijntjes E; El Bouazzaoui LH; Fokkens WJ; Brimicombe RW; Heijerman HG
    J Cyst Fibros; 2013 Sep; 12(5):525-9. PubMed ID: 23357546
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased cytokines in cystic fibrosis patients' upper airways during a new P. aeruginosa colonization.
    Jaudszus A; Arnold C; Hentschel J; Hünniger K; Baier M; Mainz JG
    Pediatr Pulmonol; 2018 Jul; 53(7):881-887. PubMed ID: 29624919
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Divergent dynamics of inflammatory mediators and multiplex PCRs during airway infection in cystic fibrosis patients and healthy controls: Serial upper airway sampling by nasal lavage.
    Erdmann N; Schilling T; Hentschel J; Lehmann T; von Bismarck P; Ankermann T; Duckstein F; Baier M; Zagoya C; Mainz JG
    Front Immunol; 2022; 13():947359. PubMed ID: 36466839
    [TBL] [Abstract][Full Text] [Related]  

  • 10. NET formation induced by Pseudomonas aeruginosa cystic fibrosis isolates measured as release of myeloperoxidase-DNA and neutrophil elastase-DNA complexes.
    Yoo DG; Floyd M; Winn M; Moskowitz SM; Rada B
    Immunol Lett; 2014 Aug; 160(2):186-94. PubMed ID: 24670966
    [TBL] [Abstract][Full Text] [Related]  

  • 11. BPI-ANCA is expressed in the airways of cystic fibrosis patients and correlates to platelet numbers and Pseudomonas aeruginosa colonization.
    Hovold G; Lindberg U; Ljungberg JK; Shannon O; Påhlman LI
    Respir Med; 2020; 170():105994. PubMed ID: 32843162
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Protease-antiprotease imbalances differ between Cystic Fibrosis patients' upper and lower airway secretions.
    Hentschel J; Fischer N; Janhsen WK; Markert UR; Lehmann T; Sonnemann J; Böer K; Pfister W; Hipler UC; Mainz JG
    J Cyst Fibros; 2015 May; 14(3):324-33. PubMed ID: 25286826
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inflammatory and immunological biomarkers are not related to survival in adults with Cystic Fibrosis.
    Moffitt KL; Martin SL; Jones AM; Webb AK; Cardwell C; Tunney MM; Elborn JS
    J Cyst Fibros; 2014 Jan; 13(1):63-8. PubMed ID: 23860440
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Secretory IgA response against Pseudomonas aeruginosa in the upper airways and the link with chronic lung infection in cystic fibrosis.
    Mauch RM; Rossi CL; Aiello TB; Ribeiro JD; Ribeiro AF; Høiby N; Levy CE
    Pathog Dis; 2017 Aug; 75(6):. PubMed ID: 28645157
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antibody responses to lipid A, core, and O sugars of the Pseudomonas aeruginosa lipopolysaccharide in chronically infected cystic fibrosis patients.
    Kronborg G; Fomsgaard A; Galanos C; Freudenberg MA; Høiby N
    J Clin Microbiol; 1992 Jul; 30(7):1848-55. PubMed ID: 1378455
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Host inflammatory responses to first isolation of Pseudomonas aeruginosa from sputum in cystic fibrosis.
    Elborn JS; Cordon SM; Shale DJ
    Pediatr Pulmonol; 1993 May; 15(5):287-91. PubMed ID: 8327287
    [TBL] [Abstract][Full Text] [Related]  

  • 17. IgA and IgG antibodies against surface antigens of Pseudomonas aeruginosa in sputum and serum from patients with cystic fibrosis.
    Schiøtz PO; Høiby N; Permin H; Wiik A
    Acta Pathol Microbiol Scand C; 1979 Jun; 87C(3):229-33. PubMed ID: 113981
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Secretory IgA-mediated immune response in saliva and early detection of Pseudomonas aeruginosa in the lower airways of pediatric cystic fibrosis patients.
    Mauch RM; Rossi CL; Nolasco da Silva MT; Bianchi Aiello T; Ribeiro JD; Ribeiro AF; Høiby N; Levy CE
    Med Microbiol Immunol; 2019 Apr; 208(2):205-213. PubMed ID: 30706137
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assessment of pulmonary antibodies with induced sputum and bronchoalveolar lavage induced by nasal vaccination against Pseudomonas aeruginosa: a clinical phase I/II study.
    Baumann U; Göcke K; Gewecke B; Freihorst J; von Specht BU
    Respir Res; 2007 Aug; 8(1):57. PubMed ID: 17683588
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum IgG and sputum IgA antibody to core lipopolysaccharide antigen from Pseudomonas cepacia in patients with cystic fibrosis.
    Nelson JW; Butler SL; Brown PH; Greening AP; Govan JR
    J Med Microbiol; 1993 Jul; 39(1):39-47. PubMed ID: 7686977
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.